S. Shevchuk
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 4
- Biosimilars and Bioanalytical Methods 4
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 9
- Rheumatoid Arthritis Research and Therapies 8
- Spondyloarthritis Studies and Treatments 7
- Economics and Econometrics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Bone and Joint Diseases 3
-
- Systemic Sclerosis and Related Diseases 3
S. Shevchuk
27 papers receiving 563 citations
Hit Papers
Peers
Comparison fields: 5 of 47
- Immunology 475
- Rheumatology 212
- Pediatrics, Perinatology and Child Health 154
- Economics and Econometrics 143
- Genetics 132
Countries citing papers authored by S. Shevchuk
This map shows the geographic impact of S. Shevchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Shevchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Shevchuk more than expected).
Fields of papers citing papers by S. Shevchuk
This network shows the impact of papers produced by S. Shevchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Shevchuk. The network helps show where S. Shevchuk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Shevchuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 1 | |
| 8 | LEVELS OF OSTEOCALCIN AND PROCOLLAGEN I N-TERMINAL PROPEPTIDE (PINP) IN MEN SUFFERING FROM ANKYLOSING SPONDYLITIS. | 2021 | 1 |
| 9 | 2020 | 1 | |
| 10 | 2020 | 7 | |
| 11 | 2019 | 0 | |
| 12 | 2017 | 0 | |
| 13 | 2016 | 0 | |
| 14 | 2015 | 6 | |
| 15 | 2014 | 3 | |
| 16 | [PATIENTS WITH HAVE A LEVEL OF ENDOTHELIN-1 AN ANTIFOSFOLIPID SYNDROME: CONNECTION IS WITH MOTION OF DISEASE, DISFUNCTION OF ENDOTHELIA AND ATHEROSCLEROSIS]. | 2014 | 1 |
| 17 | 2014 | 6 | |
| 18 | A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studybreakdown → | 2013 | 487 |
| 19 | 2013 | 1 | |
| 20 | [Dyslipidemia in patients with antiphospholipid syndrome and its association with endothelial dysfunction and atherosclerotic changes in the carotid arteries]. | 2013 | 1 |
About S. Shevchuk
S. Shevchuk is a scholar working on Rheumatology, Complementary and Manual Therapy, Orthopedics and Sports Medicine, Immunology and Pathology and Forensic Medicine, having authored 37 papers that have together received 581 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (7 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Bone and Joint Diseases (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). The work is most often cited by research in Immunology (475 citations), Rheumatology (212 citations), Pediatrics, Perinatology and Child Health (154 citations), Economics and Econometrics (143 citations) and Genetics (132 citations). S. Shevchuk has collaborated with scholars based in Ukraine, South Korea and Russia. Frequent co-authors include Dae‐Hyun Yoo, Edgar Ramiterre, Pedro C. Miranda, Ulf Müller‐Ladner, Sang Joon Lee, Paweł Hrycaj, Mauricio Abello-Banfi, Volodymyr Kovalenko, Nenad Prodanović and Won Park. Their work appears in journals such as Annals of the Rheumatic Diseases, Lupus Science & Medicine, Lupus, Journal of Medical Economics and European Journal of Plant Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.